SPH Notification from Ognian Donev for Acquired rights to issue warrants under Art. 10, point 2f of Delegated Regulation (EU) 2016/522.

SPH Presentation of the Annual Audited Individual Financial Statements of “Sopharma” AD as at 31 December 2022

SPH Sales revenues for February 2024

SPH Incoming transfer from capital increase subject to exercise of warrants from issue BG9200001212

SPH Notification from "Donev Investments Holding" AD under Art. 19 of Regulation (EU) No. 596/2014 of 08 March 2024 on the acquisition of shares from a capital increase

SPH Consolidated financial report as of 31 December 2023

SPH Results of conditional capital increase of Sopharma AD by exercising warrants from an issue with ISIN BG9200001212

SPH Notification from "Donev Investments Holding" AD under Art. 19 of Regulation (EU) No. 596/2014 of 19 February 2024 on the acquisition of shares from a temporary issue/exercise of warrants

SPH Notification from "Donev Investments Holding" AD under Art. 19 of Regulation (EU) No. 596/2014 of 19 February 2024 on the exercise of warrants in a capital increase under the condition

SPH NOTIFICATION OF INSIDERS’ TRANSACTIONS under art. 19 of Regulation 596/2014 for subscribin shares from a temporary issue/exercising warrants

SPH Notification from Ognian Donev under Art. 19 of Regulation (EU) No 596/2014 as of 20 February 2024 re exercising warrants